ARCT
Arcturus Therapeutics Holdings (ARCT)
$13
About Arcturus Therapeutics Holdings (ARCT)
Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.
Details
Daily high
$7.36
Daily low
$6.92
Price at open
--
52 Week High
$24.17
52 Week Low
$5.85
Market cap
202.6M
Dividend yield
0.00%
Volume
24
Avg. volume
829,387
P/E ratio
-2.89
Arcturus Therapeutics Holdings News
Details
Daily high
$7.36
Daily low
$6.92
Price at open
--
52 Week High
$24.17
52 Week Low
$5.85
Market cap
202.6M
Dividend yield
0.00%
Volume
24
Avg. volume
829,387
P/E ratio
-2.89